stella
beta
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation — Stella
Home
/
Bladder Carcinoma
/
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
View on ClinicalTrials.gov
Recruiting
Back to Bladder Carcinoma trials
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Trial locations
(57 sites)
United States
University of Alabama at Birmingham, Birmingham, Alabama
Ironwood Cancer & Research Centers, Chandler, Arizona
Genesis Cancer Center, Hot Springs, Arkansas
University of California, San Diego, La Jolla, California
Hoag Memorial Hospital Presbyterian, Newport Beach, California
Redwood City, Redwood City, California
Sutter Institute for Medical Research, Sacramento, California
University of Colorado, Aurora, Colorado
Memorial Healthcare System, Hollywood, Florida
The Oncology Institute of Hope & Innovation, Lakeland, Florida
Tulane Cancer Center, New Orleans, Louisiana
Christus Highland/ Boniol, Shreveport, Louisiana
Central Maine Medical Center, Lewiston, Maine
Massachusetts General Hospital, Boston, Massachusetts
Cancer & Hematology Centers of Western Michigan, Grand Rapids, Michigan
Mayo Clinic (Rochester), Rochester, Minnesota
Astera Cancer Care, East Brunswick, New Jersey
Icahn School of Medicine at Mount Sinai, New York, New York
UNC- Chapel Hill, Chapel Hill, North Carolina
The Christ Hospital Cancer Center, Cincinnati, Ohio
Cleveland Clinic, Cleveland, Ohio
Toledo Clinic Cancer Center, Toledo, Ohio
Crozer-Keystone Health System, Broomall, Pennsylvania
University of Pennsylvania, Philadelphia, Pennsylvania
Cancer Care Associates of York, York, Pennsylvania
Carolina Urologic Research Center, Myrtle Beach, South Carolina
Carolina Blood and Cancer Care Associates, Rock Hill, South Carolina
UT Southwestern Medical Center, Dallas, Texas
DHR Health Advance Care Center, Edinburg, Texas
The Center for Cancer and Blood Disorders, Forth Worth, Texas
The University of Texas Health Science Center at San Antonio, San Antonio, Texas
Utah Cancer Specialists, Salt Lake City, Utah
ThedaCare Regional Cancer Center, Appleton, Wisconsin
France
CHU Besançon, Besançon
Hôpital Franco-Britannique, Levallois-Perret
Institut Paoli-Calmettes, Marseille
Ambroise Paré-Hartmann, Neuilly
APHP Tenon Hospital - Sorbonne, Paris
Germany
Asklepios Klinik Altona, Hamburg
SLK-Kliniken Heilbronn GmbH, Heilbronn
Ludwig Maximilian University Munich, Munich
Italy
Instituto Romagnolo per lo Studio dei Tumori "Dino Amadori" IRCCS IRST, SrL, Meldola
Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia
Policlinico Universitario Agostino Gemelli, Roma
Spain
Hospital Teresa Herrera (C.H.U.A.C), A Coruña
Vall Hebron Institute of Oncology, Barcelona
Hospital Clinic of Barcelona, Barcelona
ICO Institut Catala d'Oncologia, Barcelona
Instituto Catalan de Oncologia de Girona, Girona
Hospital Universitario Insular de Gran Canaria, Las Palmas de Gran Canaria
Hospital San Carlos, Madrid
Hospital Universitario La Paz, Madrid
CIOSS HM Sanchinarro, Madrid
Hospital Universitario Virgen de la Victoria, Málaga
CCS Hospital Universitari Parc Taulí, Sabadell
Hospital Clinico de Santiago de Compostela, Santiago de Compostela
Hospital Clínico de Valencia, Valencia